We are an innovation-driven biotech company harnessing the power of nucleic acids to address major unmet medical needs.
Nucleic acids are capable of encoding vast information and executing an array of biochemical functions.
We leverage the precise structural, functional, and information encoding capabilities of nucleic acids to unlock innovative medicines and diagnostic devices.
We are the world-leading experts in nucleic acid-based diagnostics and therapeutics, backed by more than two decades of innovation.
To bring Aptitude's transformative value to market, Scott is responsible for customer development and strategic partnerships with industry leaders.
